In a new review and opinion article published in the journal Neurotherapeutics, Catherine Price, Ph.D., ABPP-CN, describes perioperative cognitive medicine as a new frontier to treat at-risk older adults with neurodegenerative disorders who require procedures with anesthesia.
Price, an associate professor and Paul Satz Term Professor who co-directs the Perioperative Cognitive Anesthesia Network (PeCAN), describes the preoperative cognitive assessment and other healthcare gaps in caring for patients with neurodegenerative diseases such as Alzheimer’s Disease. She provides a plan for phased preoperative cognitive screening, and she discusses opportunities to intervene with perioperative cognitive strategies and train health care professionals.
The review, titled “The new frontier of perioperative cognitive medicine for Alzheimer’s disease and related dementias,” was published online on Jan. 27. Neurotherapeutics is the journal of the American Society for Experimental Neurotherapeutics.
Congratulations on this exciting publication, Dr. Price!